Laporan Laba Rugi (TTM)
Laporan Laba Rugi G&E Herbal Biotechnology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 24 | 28 | 32 | 31 | 29 | 25 | 24 | 28 | 40 | 65 | 98 | 135 | 163 | 181 | 196 | 211 | 231 | 249 | 274 | 294 |
Change (%) | 18.52 | 14.88 | -4.61 | -7.11 | -14.49 | -3.98 | 17.06 | 43.66 | 62.83 | 51.88 | 37.54 | 20.54 | 11.53 | 8.07 | 7.68 | 9.33 | 7.88 | 9.93 | 7.48 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 18 | 16 | 19 | 17 | 15 | 15 | 16 | 20 | 23 | 25 | 29 | 31 | 34 | 37 | 38 | 40 | 42 | 44 | 46 | 46 |
Change (%) | -8.66 | 15.55 | -8.75 | -11.96 | -0.71 | 5.33 | 24.99 | 15.79 | 10.84 | 12.93 | 9.69 | 8.80 | 8.29 | 2.34 | 7.14 | 3.91 | 4.04 | 4.49 | 0.62 | |
% of Revenue | 74.54 | 57.44 | 57.78 | 55.27 | 52.39 | 60.83 | 66.72 | 71.24 | 57.42 | 39.09 | 29.06 | 23.18 | 20.92 | 20.31 | 19.24 | 19.14 | 18.19 | 17.54 | 16.68 | 15.61 |
Gross Operating Profit | 6 | 12 | 14 | 14 | 14 | 10 | 8 | 8 | 17 | 39 | 70 | 104 | 129 | 145 | 158 | 171 | 189 | 205 | 228 | 248 |
Change (%) | 98.12 | 13.98 | 1.06 | -1.13 | -29.65 | -18.42 | 1.15 | 112.72 | 132.95 | 76.87 | 48.95 | 24.08 | 12.39 | 9.53 | 7.81 | 10.61 | 8.74 | 11.09 | 8.86 | |
% of Revenue | 25.46 | 42.56 | 42.22 | 44.73 | 47.61 | 39.17 | 33.28 | 28.76 | 42.58 | 60.91 | 70.94 | 76.82 | 79.08 | 79.69 | 80.76 | 80.86 | 81.81 | 82.46 | 83.32 | 84.39 |
SG&A | 15 | 15 | 16 | 16 | 16 | 17 | 16 | 18 | 12 | 19 | 23 | 30 | 23 | 39 | 40 | 42 | 64 | 50 | 58 | 65 |
Change (%) | -0.28 | 7.44 | -2.23 | 3.67 | 3.53 | -2.56 | 8.84 | -34.40 | 68.20 | 20.12 | 26.66 | -21.08 | 68.01 | 2.41 | 3.61 | 53.27 | -21.22 | 14.66 | 11.98 | |
% of Revenue | 62.17 | 52.31 | 48.92 | 50.14 | 55.96 | 67.75 | 68.75 | 63.93 | 29.19 | 30.15 | 23.85 | 21.96 | 14.38 | 21.66 | 20.53 | 19.75 | 27.69 | 20.22 | 21.09 | 21.97 |
R&D | 13 | 13 | 13 | 13 | 12 | 13 | 12 | 13 | 13 | 14 | 17 | 18 | 23 | 25 | 32 | 36 | 35 | 35 | 35 | 33 |
Change (%) | 1.52 | 3.38 | -3.72 | -7.90 | 7.50 | -0.37 | 2.99 | 2.19 | 9.42 | 19.55 | 7.55 | 23.02 | 8.10 | 30.99 | 10.68 | -1.29 | 0.37 | -2.11 | -5.30 | |
% of Revenue | 52.62 | 45.07 | 40.56 | 40.93 | 40.59 | 51.03 | 52.95 | 46.59 | 33.14 | 22.27 | 17.53 | 13.71 | 13.99 | 13.56 | 16.43 | 16.89 | 15.25 | 14.19 | 12.64 | 11.13 |
OpEx | 45 | 44 | 48 | 45 | 43 | 44 | 44 | 50 | 53 | 59 | 69 | 79 | 92 | 101 | 110 | 118 | 123 | 129 | 138 | 143 |
Change (%) | -3.08 | 9.26 | -5.20 | -5.47 | 3.12 | 0.73 | 12.92 | 6.52 | 10.56 | 16.91 | 14.90 | 15.86 | 9.51 | 9.36 | 6.89 | 4.71 | 4.91 | 6.65 | 3.89 | |
% of Revenue | 189.32 | 154.81 | 147.25 | 146.34 | 148.93 | 179.61 | 188.42 | 181.75 | 134.77 | 91.51 | 70.44 | 58.85 | 56.56 | 55.53 | 56.20 | 55.78 | 53.43 | 51.96 | 50.40 | 48.72 |
Operating Income | -21 | -15 | -15 | -14 | -14 | -20 | -21 | -23 | -14 | 5 | 29 | 56 | 71 | 81 | 86 | 93 | 108 | 120 | 136 | 151 |
Change (%) | -27.27 | -0.98 | -6.45 | -1.92 | 39.12 | 6.65 | 8.24 | -38.90 | -139.77 | 428.73 | 91.49 | 27.23 | 14.17 | 6.45 | 8.71 | 15.15 | 11.29 | 13.48 | 11.14 | |
% of Revenue | -89.32 | -54.81 | -47.25 | -46.34 | -48.93 | -79.61 | -88.42 | -81.75 | -34.77 | 8.49 | 29.56 | 41.15 | 43.44 | 44.47 | 43.80 | 44.22 | 46.57 | 48.04 | 49.60 | 51.28 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||||||||||
Change (%) | 250.00 | 64.29 | 47.83 | 20.59 | -2.44 | -2.50 | ||||||||||||||
% of Revenue | -0.00 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | |||||||||||||
Net Income | -16 | -14 | -14 | -13 | -13 | -20 | -22 | -20 | -11 | 7 | 27 | 47 | 64 | 72 | 77 | 84 | 91 | 102 | 119 | 135 |
Change (%) | -8.27 | -4.21 | -3.45 | -2.12 | 53.58 | 8.44 | -8.03 | -44.51 | -167.08 | 271.97 | 71.37 | 35.04 | 13.95 | 6.33 | 8.89 | 8.61 | 12.11 | 16.55 | 13.16 | |
% of Revenue | -65.46 | -50.66 | -42.24 | -42.76 | -45.06 | -80.92 | -91.39 | -71.80 | -27.73 | 11.42 | 27.98 | 34.86 | 39.06 | 39.90 | 39.26 | 39.70 | 39.44 | 40.98 | 43.45 | 45.74 |
Source: Capital IQ